Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CORolla® TAA for Heart Failure With Preserved Ejection Fraction (HFpEF) and Diastolic Dysfunction (DD) Safety and Feasibility

NCT02499601 is registered in ClinicalTrials.gov with CorAssist Cadiovascular Ltd. as lead sponsor.

NCT NCT02499601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02499601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CORolla® TAA for Heart Failure With Preserved Ejection Fraction (HFpEF) and Diastolic Dysfunction (DD) Safety and Feasibility
Lead sponsor
CorAssist Cadiovascular Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2015
Completion date
September 30, 2024
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diastolic dysfunction, diastolic heart failure